BRIEF-Fda approves Lixisenatide as Adlyxintm for treatment of adults with type 2 diabetes in U.S. By: Reuters: Company News July 28, 2016 at 00:21 AM EDT * Fda approves lixisenatide as adlyxintm for treatment of adults with type 2 diabetes in u.s. Read More >> Related Stocks: Banco Santander ADR